Company / Free Cash Flow per Share
iBio, Inc. Free Cash Flow per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$2.18
FY2025
5-year range
-$35.62 / -$0.10
FY2021-FY2025
Trend
+93.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share returned to growth in FY2025 after 3 years of decline, reaching $-2.18.
Based on SEC 10-K filings.
-2.18 in FY2025.
Improved from $-5.13 to $-2.18 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share increased 93.9% year-over-year.
- Peak free cash flow per share was recorded in FY2016.
- Lowest free cash flow per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.36 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.18 | +93.9% |
| FY2024 | -$35.62 | -593.8% |
| FY2023 | -$5.13 | -27.9% |
| FY2022 | -$4.01 | -3798.5% |
| FY2021 | -$0.10 | +86.1% |
| FY2020 | -$0.74 | +17.8% |
| FY2019 | -$0.90 | +44.7% |
| FY2018 | -$1.63 | -1679.4% |
| FY2017 | -$0.09 | -48.9% |
| FY2016 | -$0.06 | +2.2% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026